Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 342

1.

Human and great ape red blood cells differ in plasmalogen levels and composition.

Moser AB, Steinberg SJ, Watkins PA, Moser HW, Ramaswamy K, Siegmund KD, Lee DR, Ely JJ, Ryder OA, Hacia JG.

Lipids Health Dis. 2011 Jun 17;10:101. doi: 10.1186/1476-511X-10-101.

2.

Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions.

Watkins PA, Moser AB, Toomer CB, Steinberg SJ, Moser HW, Karaman MW, Ramaswamy K, Siegmund KD, Lee DR, Ely JJ, Ryder OA, Hacia JG.

BMC Physiol. 2010 Oct 8;10:19. doi: 10.1186/1472-6793-10-19.

3.

A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts.

Steinberg SJ, Snowden A, Braverman NE, Chen L, Watkins PA, Clayton PT, Setchell KD, Heubi JE, Raymond GV, Moser AB, Moser HW.

J Inherit Metab Dis. 2009 Feb;32(1):109-19. doi: 10.1007/s10545-008-0969-8. Epub 2008 Dec 25.

PMID:
19127411
4.

Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders.

Yik WY, Steinberg SJ, Moser AB, Moser HW, Hacia JG.

Hum Mutat. 2009 Mar;30(3):E467-80. doi: 10.1002/humu.20932.

5.

Quantitative magnetization transfer characteristics of the human cervical spinal cord in vivo: application to adrenomyeloneuropathy.

Smith SA, Golay X, Fatemi A, Mahmood A, Raymond GV, Moser HW, van Zijl PC, Stanisz GJ.

Magn Reson Med. 2009 Jan;61(1):22-7. doi: 10.1002/mrm.21827.

6.

Auditory function in adrenomyeloneuropathy.

Pillion JP, Moser HW, Raymond GV.

J Neurol Sci. 2008 Jun 15;269(1-2):24-9. doi: 10.1016/j.jns.2007.12.011. Epub 2008 Jan 15.

7.

"Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.

Moser HW, Moser AB, Hollandsworth K, Brereton NH, Raymond GV.

J Mol Neurosci. 2007 Sep;33(1):105-13. Review.

PMID:
17901554
8.

Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study.

Mahmood A, Raymond GV, Dubey P, Peters C, Moser HW.

Lancet Neurol. 2007 Aug;6(8):687-92.

PMID:
17618834
9.

Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy.

Eichler F, Mahmood A, Loes D, Bezman L, Lin D, Moser HW, Raymond GV.

Arch Neurol. 2007 May;64(5):659-64.

PMID:
17502464
10.

New insights about hematopoietic stem cell transplantation in adrenoleukodystrophy.

Moser HW, Mahmood A.

Arch Neurol. 2007 May;64(5):631-2. No abstract available.

PMID:
17502460
11.

X-linked adrenoleukodystrophy.

Moser HW, Mahmood A, Raymond GV.

Nat Clin Pract Neurol. 2007 Mar;3(3):140-51. Review.

PMID:
17342190
12.

Peroxisome biogenesis disorders.

Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW.

Biochim Biophys Acta. 2006 Dec;1763(12):1733-48. Epub 2006 Sep 14. Review.

13.

Peripheral nerve involvement in Krabbe disease: a guide to therapy selection and evaluation.

Moser HW.

Neurology. 2006 Jul 25;67(2):201-2. No abstract available.

PMID:
16864808
14.

Therapy of X-linked adrenoleukodystrophy.

Moser HW.

NeuroRx. 2006 Apr;3(2):246-53. Review.

15.

Sensorimotor function and axonal integrity in adrenomyeloneuropathy.

Zackowski KM, Dubey P, Raymond GV, Mori S, Bastian AJ, Moser HW.

Arch Neurol. 2006 Jan;63(1):74-80.

PMID:
16401738
16.

Cognitive evaluation of neurologically asymptomatic boys with X-linked adrenoleukodystrophy.

Cox CS, Dubey P, Raymond GV, Mahmood A, Moser AB, Moser HW.

Arch Neurol. 2006 Jan;63(1):69-73.

PMID:
16401737
17.

Adrenoleukodystrophy: new approaches to a neurodegenerative disease.

Moser HW, Raymond GV, Dubey P.

JAMA. 2005 Dec 28;294(24):3131-4.

PMID:
16380594
18.

Adreno-leukodystrophy: oxidative stress of mice and men.

Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW, Watkins PA, Smith KD.

J Neuropathol Exp Neurol. 2005 Dec;64(12):1067-79.

PMID:
16319717
19.

X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes.

Mahmood A, Dubey P, Moser HW, Moser A.

Pediatr Transplant. 2005 Dec;9 Suppl 7:55-62. Review.

PMID:
16305618
20.
21.

Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy.

Dubey P, Fatemi A, Huang H, Nagae-Poetscher L, Wakana S, Barker PB, van Zijl P, Moser HW, Mori S, Raymond GV.

Ann Neurol. 2005 Nov;58(5):758-66.

PMID:
16240348
22.

Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.

Moser HW, Raymond GV, Lu SE, Muenz LR, Moser AB, Xu J, Jones RO, Loes DJ, Melhem ER, Dubey P, Bezman L, Brereton NH, Odone A.

Arch Neurol. 2005 Jul;62(7):1073-80.

PMID:
16009761
23.

Magnetization transfer weighted imaging in the upper cervical spinal cord using cerebrospinal fluid as intersubject normalization reference (MTCSF imaging).

Smith SA, Golay X, Fatemi A, Jones CK, Raymond GV, Moser HW, van Zijl PC.

Magn Reson Med. 2005 Jul;54(1):201-6.

24.

Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy.

Fatemi A, Smith SA, Dubey P, Zackowski KM, Bastian AJ, van Zijl PC, Moser HW, Raymond GV, Golay X.

Neurology. 2005 May 24;64(10):1739-45.

PMID:
15911801
25.

Genetic causes of mental retardation.

Moser HW.

Ann N Y Acad Sci. 2004 Dec;1038:44-8.

PMID:
15838096
26.

Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening.

Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW.

J Pediatr. 2005 Apr;146(4):528-32.

PMID:
15812458
27.

Alexander disease: combined gene analysis and MRI clarify pathogenesis and extend phenotype.

Moser HW.

Ann Neurol. 2005 Mar;57(3):307-8. No abstract available.

PMID:
15732119
28.

Magnetic resonance spectroscopy: a new guide for the therapy of adrenoleukodystrophy.

Moser HW, Barker PB.

Neurology. 2005 Feb 8;64(3):406-7. No abstract available.

PMID:
15699364
29.

Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.

Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV.

Neurology. 2005 Jan 25;64(2):304-10.

PMID:
15668429
30.

Inhibition of peroxisomal functions due to oxidative imbalance induced by mistargeting of catalase to cytoplasm is restored by vitamin E treatment in skin fibroblasts from Zellweger syndrome-like patients.

Kawada Y, Khan M, Sharma AK, Ratnayake DB, Dobashi K, Asayama K, Moser HW, Contreras MA, Singh I.

Mol Genet Metab. 2004 Dec;83(4):297-305.

PMID:
15589116
31.

Evaluation of therapy of X-linked adrenoleukodystrophy.

Moser HW, Fatemi A, Zackowski K, Smith S, Golay X, Muenz L, Raymond G.

Neurochem Res. 2004 May;29(5):1003-16. Review. No abstract available.

PMID:
15139299
32.

Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.

Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T, Grewal SS, Orchard PJ, Abel SL, Goldman AI, Ramsay NK, Dusenbery KE, Loes DJ, Lockman LA, Kato S, Aubourg PR, Moser HW, Krivit W.

Blood. 2004 Aug 1;104(3):881-8. Epub 2004 Apr 8. Erratum in: Blood. 2004 Dec 15;104(13):3857.

PMID:
15073029
33.

Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.

Moser HW, Raymond GV, Koehler W, Sokolowski P, Hanefeld F, Korenke GC, Green A, Loes DJ, Hunneman DH, Jones RO, Lu SE, Uziel G, Giros ML, Roels F.

Adv Exp Med Biol. 2003;544:369-87. No abstract available.

PMID:
14713253
34.

Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease.

Pizzini F, Fatemi AS, Barker PB, Nagae-Poetscher LM, Horská A, Zimmerman AW, Moser HW, Bibat G, Naidu S.

AJNR Am J Neuroradiol. 2003 Sep;24(8):1683-9.

35.

Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy.

Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW, Raymond GV.

Neurology. 2003 Aug 12;61(3):369-74.

PMID:
12913200
36.

Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.

Matsumoto N, Tamura S, Furuki S, Miyata N, Moser A, Shimozawa N, Moser HW, Suzuki Y, Kondo N, Fujiki Y.

Am J Hum Genet. 2003 Aug;73(2):233-46. Epub 2003 Jul 8.

37.

Clinical and electrophysiological improvement of adrenomyeloneuropathy with steroid treatment.

Zhang LX, Bakshi R, Fine E, Moser HW.

J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):822-3. No abstract available.

38.

MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy.

Fatemi A, Barker PB, Uluğ AM, Nagae-Poetscher LM, Beauchamp NJ, Moser AB, Raymond GV, Moser HW, Naidu S.

Neurology. 2003 Apr 22;60(8):1301-7.

PMID:
12707433
39.

Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids.

Tagawa Y, Laroy W, Nimrichter L, Fromholt SE, Moser AB, Moser HW, Schnaar RL.

Neurochem Res. 2002 Aug;27(7-8):847-55.

PMID:
12374222
40.

Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience.

Eichler FS, Itoh R, Barker PB, Mori S, Garrett ES, van Zijl PC, Moser HW, Raymond GV, Melhem ER.

Radiology. 2002 Oct;225(1):245-52.

PMID:
12355012
41.

Brain glucose metabolism in Rett Syndrome.

Villemagne PM, Naidu S, Villemagne VL, Yaster M, Wagner HN Jr, Harris JC, Moser HW, Johnston MV, Dannals RF, Wong DF.

Pediatr Neurol. 2002 Aug;27(2):117-22.

PMID:
12213612
42.

Cerebral X-linked adrenoleukodystrophy in a girl with Xq27-Ter deletion.

Hershkovitz E, Narkis G, Shorer Z, Moser AB, Watkins PA, Moser HW, Manor E.

Ann Neurol. 2002 Aug;52(2):234-7.

PMID:
12210797
43.

Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.

Corzo D, Gibson W, Johnson K, Mitchell G, LePage G, Cox GF, Casey R, Zeiss C, Tyson H, Cutting GR, Raymond GV, Smith KD, Watkins PA, Moser AB, Moser HW, Steinberg SJ.

Am J Hum Genet. 2002 Jun;70(6):1520-31. Epub 2002 Apr 29.

44.

Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy.

Eichler FS, Barker PB, Cox C, Edwin D, Ulug AM, Moser HW, Raymond GV.

Neurology. 2002 Mar 26;58(6):901-7.

PMID:
11914405
45.

Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking.

Mori S, Kaufmann WE, Davatzikos C, Stieltjes B, Amodei L, Fredericksen K, Pearlson GD, Melhem ER, Solaiyappan M, Raymond GV, Moser HW, van Zijl PC.

Magn Reson Med. 2002 Feb;47(2):215-23.

46.

ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations.

Kemp S, Pujol A, Waterham HR, van Geel BM, Boehm CD, Raymond GV, Cutting GR, Wanders RJ, Moser HW.

Hum Mutat. 2001 Dec;18(6):499-515. Review.

PMID:
11748843
47.

Neuroimaging studies in Rett syndrome.

Naidu S, Kaufmann WE, Abrams MT, Pearlson GD, Lanham DC, Fredericksen KA, Barker PB, Horska A, Golay X, Mori S, Wong DF, Yablonski M, Moser HW, Johnston MV.

Brain Dev. 2001 Dec;23 Suppl 1:S62-71. Review.

PMID:
11738844
48.
49.
50.

Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases.

Watkins PA, Hamilton JA, Leaf A, Spector AA, Moore SA, Anderson RE, Moser HW, Noetzel MJ, Katz R.

J Mol Neurosci. 2001 Apr-Jun;16(2-3):87-92; discussion 151-7.

PMID:
11478388

Supplemental Content

Loading ...
Support Center